Over-the-counter drug · ANDA
Morning After Pill (levonorgestrel) NDC 73436-8292
Levonorgestrel 1.5 mg/1 · Tablet · Oral · Cadence Health Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73436-8292-1 | 73436829201 | 1 BLISTER PACK in 1 BOX, UNIT-DOSE (73436-8292-1) / 1 TABLET in 1 BLISTER PACKMarketed from Apr 15, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Morning After Pill
- Generic name (nonproprietary)
- levonorgestrel
- Active ingredients
- Levonorgestrel — 1.5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Cadence Health Inc
- Product type
- Over-the-counter drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207660
- Marketing start
- Listing expires
- Other FDA classes
- Inhibit Ovum Fertilization (Physiologic effect)Progesterone Congeners (Chemical structure)Progesterone Congeners (Chemical structure)
- Identifiers
- Product ID 73436-8292_32e9d9ba-b359-4826-e063-6294a90a927bSPL ID 32e9d9ba-b359-4826-e063-6294a90a927bSPL set ID 2fb59f53-d885-9d4a-e063-6394a90a88ccRxCUI 483325, 1657617UNII 5W7SIA7YZW
- Pharmacologic class
- Progestin; Progestin-containing Intrauterine System
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N473436829201followed by a unit qualifier and the quantityPackage 73436-8292-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Use for women to reduce chance of pregnancy after unprotected sex (if a contraceptive failed or if you did not use birth control)
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 207660
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Restartlevonorgestrel | Levonorgestrel 1.5 mg/1 | TabletOral | Winx Health Inc. | 80584-103 |
| My Choicelevonorgestrel | Levonorgestrel 1.5 mg/1 | TabletOral | OHM LABORATORIES INC | 51660-096 |
| My After Planlevonorgestrel | Levonorgestrel 1.5 mg/1 | TabletOral | OHM LABORATORIES INC | 51660-098 |
| Julielevonorgestrel | Levonorgestrel 1.5 mg/1 | TabletOral | Julie Products Inc | 82791-335 |
| Levonorgestrel | Levonorgestrel 1.5 mg/1 | TabletOral | Naari Pte Limited | 79929-016 |